Reyhaneh Yousefi M.Sc., Tair Ben-Porat Ph.D., Ariany Marques Vieira M.Sc., Kim L. Lavoie Ph.D., Simon L. Bacon Ph.D., REBORN Study Team, S.L. Bacon, K.L. Lavoie, A. Gautier, P. Marion, A. Alberga, R. Denis, P. Garneau, G. Lavigne, R. Pescarus, S. Raymond-Carrier, S. Santosa, A.S. Studer, T. Ben-Porat, K. Delaney, A. Fortin, C. Julien, L. Mercier, R. Woods, R. Yousef
{"title":"Who gains the most quality-of-life benefits from metabolic and bariatric surgery: findings from the prospective REBORN cohort study","authors":"Reyhaneh Yousefi M.Sc., Tair Ben-Porat Ph.D., Ariany Marques Vieira M.Sc., Kim L. Lavoie Ph.D., Simon L. Bacon Ph.D., REBORN Study Team, S.L. Bacon, K.L. Lavoie, A. Gautier, P. Marion, A. Alberga, R. Denis, P. Garneau, G. Lavigne, R. Pescarus, S. Raymond-Carrier, S. Santosa, A.S. Studer, T. Ben-Porat, K. Delaney, A. Fortin, C. Julien, L. Mercier, R. Woods, R. Yousef","doi":"10.1016/j.soard.2024.08.029","DOIUrl":null,"url":null,"abstract":"Prioritizing patients for metabolic and bariatric surgery (MBS) based on their potential postoperative benefits is essential. To examine changes in quality of life (QoL) during the initial postoperative year among patients with diverse eligibility statuses and determine which group experiences greater benefits. Center intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de- Montréal (CIUSSS-NIM), Canada. We categorized patients into 3 groups based on obesity class and the presence of comorbidities: Group 1 (obesity class II without comorbidities, n = 28); Group 2 (obesity class II with comorbidities, n = 36); and Group 3 (obesity class III, n = 460). QoL (Short-Form QoL questionnaire [SF-12]) and anthropometrics were measured at 6 months before, and 6 and 12 months after surgery. Repeated measures mixed models revealed a significant main effect of time ( < .001) and an interaction between time and group for the physical component of QoL ( = .007). These indicated consistent improvements across time in all groups, with the greatest benefits seen in Group 3 relative to Group 1. There were no interactions between time and group for the mental components of QoL ( = .402). There were significant interaction effects for weight and BMI (p’s < .001), with Group 3 losing more weight than Groups 1 or 2. All groups that underwent MBS had improvements in the physical aspects of QoL and weight over time, even those who have traditionally not be considered eligible for MBS (i.e., Group 1). This provides a starting point to explore the importance of not excluding patients due to their weight and comorbidity status and setting comprehensive eligibility criteria encompassing all patients who might benefit from MBS, beyond just weight loss.","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":null,"pages":null},"PeriodicalIF":3.5000,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery for Obesity and Related Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.soard.2024.08.029","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Prioritizing patients for metabolic and bariatric surgery (MBS) based on their potential postoperative benefits is essential. To examine changes in quality of life (QoL) during the initial postoperative year among patients with diverse eligibility statuses and determine which group experiences greater benefits. Center intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de- Montréal (CIUSSS-NIM), Canada. We categorized patients into 3 groups based on obesity class and the presence of comorbidities: Group 1 (obesity class II without comorbidities, n = 28); Group 2 (obesity class II with comorbidities, n = 36); and Group 3 (obesity class III, n = 460). QoL (Short-Form QoL questionnaire [SF-12]) and anthropometrics were measured at 6 months before, and 6 and 12 months after surgery. Repeated measures mixed models revealed a significant main effect of time ( < .001) and an interaction between time and group for the physical component of QoL ( = .007). These indicated consistent improvements across time in all groups, with the greatest benefits seen in Group 3 relative to Group 1. There were no interactions between time and group for the mental components of QoL ( = .402). There were significant interaction effects for weight and BMI (p’s < .001), with Group 3 losing more weight than Groups 1 or 2. All groups that underwent MBS had improvements in the physical aspects of QoL and weight over time, even those who have traditionally not be considered eligible for MBS (i.e., Group 1). This provides a starting point to explore the importance of not excluding patients due to their weight and comorbidity status and setting comprehensive eligibility criteria encompassing all patients who might benefit from MBS, beyond just weight loss.
期刊介绍:
Surgery for Obesity and Related Diseases (SOARD), The Official Journal of the American Society for Metabolic and Bariatric Surgery (ASMBS) and the Brazilian Society for Bariatric Surgery, is an international journal devoted to the publication of peer-reviewed manuscripts of the highest quality with objective data regarding techniques for the treatment of severe obesity. Articles document the effects of surgically induced weight loss on obesity physiological, psychiatric and social co-morbidities.